8-K: InMed Pharma Sets 2025 Annual Meeting Dates
Annual Meeting Announcement
InMed Pharmaceuticals Inc. announced the dates and record information for its 2025 Annual General Meeting of shareholders.
Summary
- InMed Pharmaceuticals Inc. has scheduled its 2025 Annual General Meeting for December 17, 2025.
- The record date for both the notice of meeting and voting eligibility is set for October 22, 2025.
- The beneficial ownership determination date is also October 22, 2025.
- Common Shares are the class of securities entitled to vote at the meeting.
- The company will utilize 'Notice and Access' for both beneficial and registered holders for proxy materials.
Sentiment
Score: 5
Explanation: The filing is an administrative announcement regarding the annual general meeting, providing no financial or operational updates to influence sentiment.
Future Outlook
The filing does not provide any forward-looking statements or guidance beyond the administrative details of the upcoming annual general meeting.
Management Comments
- Eric A. Adams, President and CEO, signed the report on behalf of InMed Pharmaceuticals Inc.
Industry Context
This announcement is a standard corporate governance event, common across publicly traded companies, and does not reflect specific industry trends or competitive dynamics within the pharmaceutical sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Annual Meeting Scheduling | Announcement of the 2025 Annual General Meeting date, record dates for notice and voting, and beneficial ownership determination date. | 2025-09-23 | Ensures compliance with corporate governance requirements and provides shareholders with necessary information to participate in the annual meeting. |
Stakeholder Impact
- Shareholders: Provides critical dates for participation in the Annual General Meeting, including voting rights and receipt of meeting notices.
Next Steps
- Distribution of proxy materials to shareholders using 'Notice and Access' for both beneficial and registered holders.
- Holding of the Annual General Meeting on December 17, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-09-23 | Date of report and announcement of annual meeting details. |
| 2025-10-22 | Record Date for Notice of Meeting, Record Date for Voting, and Beneficial Ownership Determination Date. |
| 2025-12-17 | Date of the Annual General Meeting. |
Keywords
InMed Pharmaceuticals, Annual General Meeting, Shareholder Meeting, Record Date, Corporate Governance, INM, Nasdaq
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.